Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
FDA requests more restrictions on ovarian cancer drugs
Several companies have already withdrawn their respective PARP inhibitors for heavily pretreated patients with ovarian cancer.
News
‘Plethora’ of new MCL treatment options
New and potential treatments have emerged for relapsed/refractory mantle cell lymphoma (R/RMCL), a rare but steadily increasing form of non-...
News
New guidance on acupuncture, massage, yoga for cancer pain
The new guideline “takes a deeper dive on the use of integrative therapies, which is important because clinicians and patients need to have access...
News
Stronger evidence that exercise lowers breast cancer risk
“Increasing physical activity and reducing sedentary time are already recommended for cancer prevention. Our study adds further evidence that such...
News
Intera Oncology recalls hepatic artery infusion pumps for possible life-threatening issue
The recall follows reports from clinicians that the pumps, which are implanted to deliver chemotherapy to treat liver tumors, were delivering...
News
Reducing alcohol intake may reduce cancer risk
Study suggests cancer risk can be meaningfully altered by changing the amount of alcoholic beverages consumed.
News
FDA warns of increased risk of death with CLL, lymphoma drug
“The trial also found Copiktra was associated with a higher risk of serious side effects ...”
News
FDA approves liso-cel as second-line therapy for LBCL
Liso-cel could now become a “new standard of care for patients after failure of first-line therapy,” offering significantly improved outcomes for...
News
International trial finds best regimen for Ewing sarcoma
This is the first randomized head-to-head comparison of chemotherapy regimens in patients with this rare and deadly disease.
News
Telemedicine in cancer care: Not all patients can access
Health care providers concerned that telemedicine expansion could widen cancer care disparities.
News
‘Unlimited’ cancer costs: The Medicare Part D dilemma
Many patients with cancer who rely on Medicare Part D face an impossible choice: “Your money or your life.”
News
Imiquimod cream offers alternative to surgery for vulvar lesions
Good patient compliance is important for treatment with imiquimod to be successful and that surgery might remain the treatment of choice for...
News
Lung cancer in 2030: Expand genotyping
Improve the ability to treat patients based on risk level and expand the use of targeted therapies.
News
Weighing the complexity of pathological response in lung cancer
Future work should aim to standardize pathology assessment.
News
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.